OUTCOME OF PATIENTS WITH FLT3 MUTATED ACUTE MYELOID LEUKEMIA IN FIRST RELAPSE

Mutations of Fms-like tyrosine kinase-3 (FLT3) have been described in about 30% of patients with acute myeloid leukemia (AML) and are associated with a shorter disease-free and overall survival after initial therapy. We sought to examine whether the presence of these mutations in relapsed disease wa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ravandi, Farhad, Kantarjian, Hagop, Faderl, Stefan, Garcia-Manero, Guillermo, O’Brien, Susan, Koller, Charles, Pierce, Sherry, Brandt, Mark, Kennedy, Deborah, Cortes, Jorge, Beran, Miloslav
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4082769/
https://ncbi.nlm.nih.gov/pubmed/19878996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2009.10.001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki